Autism in Adulthood: Clinical and Demographic Characteristics of a Cohort of Five Hundred Persons with Autism Analyzed by a Novel Multistep Network Model
Abstract:Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by deficits in communication and relational skills, associated with repetitive verbal and motor behaviors, restricted patterns of interest, need for a predictable and stable environment, and hypo- or hypersensitivity to sensory inputs. Due to the challenging diagnosis and the paucity of specific interventions, persons with autism (PWA) reaching the adult age often display a severe functional regression. In this scenario, the … Show more
“…Concerning patient's perspective with health outcome, a complete habilitative daily program, based on behavioral therapy in a small ASD group, has been provided from Adult autism center and Social Agency to improve social skill but very little improvement has been obtained, so the treatment was further based on care and support (Keller et al, 2020).…”
De novo variants in the WDR26 gene leading to haploinsufficiency have recently been associated with Skraban‐Deardorff syndrome. This condition is an ultra‐rare autosomal dominant neurodevelopmental disorder characterized by a broad range of clinical signs, including intellectual disability (ID), developmental delay (DD), seizures, abnormal facial features, feeding difficulties, and minor skeletal anomalies. Currently, 18 cases have been reported in the literature and for only 15 of them a clinical description is available. Here, we describe a child with Skraban‐Deardorff syndrome associated with the WDR26 pathogenic de novo variant NM_025160.6:c.69dupC, p.(Gly24ArgfsTer48), and an adult associated with the pathogenic de novo variant c.1076G > A, p.(Trp359Ter). The adult patient was a 29‐year‐old female with detailed information on clinical history and pharmacological treatments since birth, providing an opportunity to map disease progression and patient management. By comparing our cases with published reports of Skraban‐Deardorff syndrome, we provide a genetic and clinical summary of this ultrarare condition, describe the clinical management from childhood to adult age, and further expand on the clinical phenotype.
“…Concerning patient's perspective with health outcome, a complete habilitative daily program, based on behavioral therapy in a small ASD group, has been provided from Adult autism center and Social Agency to improve social skill but very little improvement has been obtained, so the treatment was further based on care and support (Keller et al, 2020).…”
De novo variants in the WDR26 gene leading to haploinsufficiency have recently been associated with Skraban‐Deardorff syndrome. This condition is an ultra‐rare autosomal dominant neurodevelopmental disorder characterized by a broad range of clinical signs, including intellectual disability (ID), developmental delay (DD), seizures, abnormal facial features, feeding difficulties, and minor skeletal anomalies. Currently, 18 cases have been reported in the literature and for only 15 of them a clinical description is available. Here, we describe a child with Skraban‐Deardorff syndrome associated with the WDR26 pathogenic de novo variant NM_025160.6:c.69dupC, p.(Gly24ArgfsTer48), and an adult associated with the pathogenic de novo variant c.1076G > A, p.(Trp359Ter). The adult patient was a 29‐year‐old female with detailed information on clinical history and pharmacological treatments since birth, providing an opportunity to map disease progression and patient management. By comparing our cases with published reports of Skraban‐Deardorff syndrome, we provide a genetic and clinical summary of this ultrarare condition, describe the clinical management from childhood to adult age, and further expand on the clinical phenotype.
“…Autism spectrum disorder (ASD) is the diagnostic label that refers to a set of neurodevelopmental conditions characterized by impairment in social abilities, repetitive behaviors, restricted interests and abnormal sensory processing ( American Psychiatric Association, 2013 ). This cluster of conditions reports clinical features persisting throughout the lifespan ( Brighenti et al, 2018 , Keller et al, 2020 , Lord et al, 2018 ) and afflicting approximately 1 in 54 children aged 8 years ( Baio et al, 2018 ).…”
Highlights
We present an innovative connectomic approach based on voxel-based morphometry (VBM)
meta
-data.
We mapped the topological configuration of gray matter abnormalities in autism spectrum disorder (ASD).
ASD co-alteration network tends to overlap with the pathways of structural brain connectivity.
Recognizable cerebral pathological hubs were captured by graph-analysis.
A core sub-network was identified, which provides insight into our understanding of ASD.
“…The fact that dysfunctions in GABAergic signaling are a common pathogenetic trait shared by a large array of brain disorders highlights the presence of psychopathological and neurological co-occurrences in many neurodevelopmental disorders. Transition of persons with ASD to adulthood is often accompanied by high rates of psychiatric comorbidities [ 150 ]. In prefrontal cortical regions, parvalbumin-expressing GABAergic interneurons normally mature during adolescence, and are particularly affected during their development by oxidative stress, neuroinflammation and NMDAR hypofunction [ 78 ]; in fact, in patients with schizophrenia, autism and bipolar disorders, they exhibit a pattern of gene expression typical of immature cells [ 151 ].…”
In neuronal precursors and immature neurons, the depolarizing (excitatory) effect of γ-Aminobutyric acid (GABA) signaling is associated with elevated [Cl−]i; as brain cells mature, a developmental switch occurs, leading to the decrease of [Cl−]i and to the hyperpolarizing (inhibitory) effect of GABAergic signaling. [Cl−]i is controlled by two chloride co-transporters: NKCC1, which causes Cl− to accumulate into the cells, and KCC2, which extrudes it. The ontogenetic upregulation of the latter determines the above-outlined switch; however, many other factors contribute to the correct [Cl−]i in mature neurons. The dysregulation of chloride homeostasis is involved in seizure generation and has been associated with schizophrenia, Down’s Syndrome, Autism Spectrum Disorder, and other neurodevelopmental disorders. Recently, much effort has been put into developing new drugs intended to inhibit NKCC1 activity, while no attention has been paid to the origin of [Cl−]i dysregulation. Our study examines the pathophysiology of Cl− homeostasis and focuses on the impact of oxidative stress (OS) and inflammation on the activity of Cl− co-transporters, highlighting the relevance of OS in numerous brain abnormalities and diseases. This hypothesis supports the importance of primary prevention during pregnancy. It also integrates the therapeutic framework addressed to restore normal GABAergic signaling by counteracting the alteration in chloride homeostasis in central nervous system (CNS) cells, aiming at limiting the use of drugs that potentially pose a health risk.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.